TractionOWKIN partners with leading pharmaceutical companies including Amgen and Actelion and has programs in development with Institut Curie, Centre Leon Berard and Saint Louis Hospital.Organizations InvolvedAmgen, Actelion, Institut Curie, Centre Leon Berard, Saint Louis HospitalFoundersThomas Clozel, M.D.MarketPharmaceuticalsLocationNew York, NY, USACoinvestorsCathay Innovation, NJF Capital, Otium Venture, Plug & Play Ventures Company Description
OWKIN is a predictive analytics company that utilizes transfer learning to accelerate drug discovery and development. OWKIN's proprietary platform, OWKIN Socrates uses machine learning-based modeling to analyze molecular, imaging libraries and patient datasets to uncover complex biomarker patterns that cause disease.